Forward PE Ratio: 26.62
The forward PE ratio is 26.62 as of Thursday, July 9, 2026.
Forward PE Ratio (26.62) = Close Price ($40.85) / Consensus Forward EPS ($1.51)
MDLN Forward PE Ratio Metrics
FORWARD PE RATIO
26.62
MDLN Competitors' Forward PE Ratio
Medline Inc.
Market Cap
$34.54B
Forward PE Ratio
26.62
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Medline Inc. (MDLN) | $34.54B | 26.62 |
| IQVIA Holdings Inc. (IQV)vs › | $34.88B | 15.90 |
| Centene Corp. (CNC)vs › | $33.38B | 19.16 |
| Zoetis Inc. (ZTS)vs › | $31.48B | 10.91 |
| Agilent Technologies, Inc. (A)vs › | $37.73B | 21.31 |
| Veeva Systems Inc. (VEEV)vs › | $30.82B | 23.70 |
| Moderna, Inc. (MRNA)vs › | $30.38B | N/A |
| ResMed Inc. (RMD)vs › | $30.24B | 18.53 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.43B | 13.25 |
| Biogen Inc. (BIIB)vs › | $29.37B | 13.80 |
Trailing vs Forward
Trailing P/E
33.3
reported TTM EPS
Forward P/E
26.6
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $1.51 implies +24.8% EPS growth vs the reported trailing $1.21.
Forward P/E by Fiscal Year
View All Analyst EstimatesAt today's $40.85 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.51 | $1.45 – $1.56 | 15 | 27.0x |
| 2027-12-31 | $1.66 | $1.59 – $1.70 | 15 | 24.6x |
| 2028-12-31 | $1.87 | $1.65 – $2.10 | 9 | 21.8x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
Forward PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Forward PE Ratio FAQ
- What is the forward PE ratio for Medline Inc. (MDLN)?
- The forward PE ratio for MDLN stock is 26.62.
Related Metrics
About Medline Inc.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- James Boyle